Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
Clinical trial NCT04231214 · COMPLETED
Trial details
- NCT number
- NCT04231214
- Sponsor
- Fraunhofer-Institute of Toxicology and Experimental Medicine
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2023-04-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.